Labiotech.eu

News and Trends 3 Mar 2015

ICON Completes the Acquisition of MediMedia Pharma Solutions

ICON plc completed the acquisition of MediMedia Pharma Solutions, creating the industry’s leading integrated market access solution. Headquartered in Dublin, ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical […]

March 3, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 3 Mar 2015

Calixar Raises €1 Million to License-out its Isolation Technologies

CALIXAR, develops new approaches to isolate in solution – with the highest purity levels – full-length membrane antigens and proteins, whilst keeping their structural and functional integrity. The company announced the completion of its second round of financing with its historical investors, Bpifrance (French public investment bank) and the Banque Populaire. The aim of this […]

March 3, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 2 Mar 2015

Monsanto Reaffirms its Commitment in Europe

While the “Salon International de l’Agriculture 2015” has just closed its doors in Paris, Monsanto, a global provider of leading technology solutions and products that improves farm productivity, reaffirms its commitment to the European market of seeds. Monsanto’s strategy includes investments of €500 million over ten years to develop the company’s production capacity in Europe […]

March 2, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 28 Feb 2015

The biotechnologies applied to the veterinary science, the markets by 2018

France was the first country where the veterinary studies have become institutionalized through the establishment of the first veterinary schools in the eighteenth century. Veterinary science is vital to the study and protection of livestock, herd health and monitoring the spread of disease. It requires the acquisition and application of scientific knowledge in multiple areas […]

February 28, 2015 - 5 minutesmins - By Cédric Brock

News and Trends 27 Feb 2015

Sanofi: Get Ready for the Launch of the First Inhaled Insulin in the U.S.

Sanofi, the global healthcare leader has core strengths in the field of healthcare due to its seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. This article will focus on Sanofi Diabetes. In August 2014, our previous article “Sanofi buys Mannkind’s inhaled insulin for €824.5m” […]

February 27, 2015 - 3 minutesmins - By Joachim Eeckhout

Orca Pharmaceuticals AstraZeneca autoimmune2

News and Trends 27 Feb 2015

Orca Pharmaceuticas Associates with AstraZeneca to Identify Best-in-Class RORγ Inhibitors

Orca Pharmaceuticals, and AstraZeneca embarked on a three year collaboration to develop inhibitors of retinoic acid-related orphan nuclear receptor gamma (RORγ). Inhibitors of this receptor are believed to have potential against a wide range of autoimmune diseases for which there is currently no safe, orally available and effective treatment. RORγ plays a key role in […]

February 27, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 Feb 2015

SSB’s Ambr Bioreactor Systems Enhanced with Software for Design of Experiments

The French company, Sartorius Stedim Biotech (SSB), announced that the 2015 version of the Ambr systems (Ambr 15 and Ambr 250) will be supplied with integrated BioPAT MODDE Software for Design of Experiments (DoE), powered by Umetrics. This will allow bioprocess scientists to easily implement DoE into their work flow for simpler process optimization and […]

February 26, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 Feb 2015

Celltrion launches world’s first biosimilar monoclonal antibody in 12 new European markets

Celltrion Healthcare has today announced the launch of Remsima (infliximab) in 12 European markets: Austria, Belgium, Denmark, France, Germany, Greece, Italy, Luxembourg, the Netherlands, Spain, Sweden and the UK. The treatment to the treatment of autoimmune diseases is now available in 31 countries. Remsima, developed by the South Korean company Celltrion, is the world’s first biosimilar monoclonal […]

February 26, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 Feb 2015

Unstoppable Ferring after the Acquisition of a novel Oral Drug Delivery Technology

Ferring Pharmaceuticals signed an agreement with South Korean CTCBIO to acquire rights to a novel oral drug delivery technology. The Swiss company is growing more and more rapidly with plenty of updates since the begining of the year. Ferring’s success in developing oral formulations for peptide drugs including the world’s first orally active peptide, desmopressin […]

February 26, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 25 Feb 2015

Ipsen buys an option to Acquire Canbex

Canbex, a spin-off of University College London (UCL) that raised a Series A financing of €2.8M in 2013 from MS Ventures, may become part of Ipsen. The French giant payed €6M upfront for the option to purchase 100% of Canbex shares upon completion of the Phase IIa study of Canbex’s lead candidate for the treatment […]

February 25, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 25 Feb 2015

Cellectis is preparing its IPO in the U.S

Cellectis is a company focused on developing immunotherapies based on gene edited engineered CAR-T cells. The company’s mission is to develop a new generation of cancer therapies based on engineered T-cells. With 15 years of expertise, Cellectis is already listed on the NYSE Alternext market (ticker: ALCLS) and now preparing its IPO to be listed on the […]

February 25, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 24 Feb 2015

Cobra Biologics and Manchester University Awarded €296.4K

The University of Manchester and Cobra Biologics, biologics and pharmaceuticals manufacturer, have been awarded €296.4K by Innovate UK and the Biotechnology and Biological Sciences Research Council (BBSRC). The project is one of the only 23 which will share almost €27.3M given away by the competition that intends to bring innovative biotechnology projects to market. The joint […]

February 24, 2015 - 2 minutesmins - By Lourdes Riquelme

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

ICON Completes the Acquisition of MediMedia Pharma Solutions

Calixar Raises €1 Million to License-out its Isolation Technologies

Monsanto Reaffirms its Commitment in Europe

The biotechnologies applied to the veterinary science, the markets by 2018

Sanofi: Get Ready for the Launch of the First Inhaled Insulin in the U.S.

Orca Pharmaceuticas Associates with AstraZeneca to Identify Best-in-Class RORγ Inhibitors

SSB’s Ambr Bioreactor Systems Enhanced with Software for Design of Experiments

Celltrion launches world’s first biosimilar monoclonal antibody in 12 new European markets

Unstoppable Ferring after the Acquisition of a novel Oral Drug Delivery Technology

Ipsen buys an option to Acquire Canbex

Cellectis is preparing its IPO in the U.S

Cobra Biologics and Manchester University Awarded €296.4K

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!